diphyllin has been researched along with glucose, (beta-d)-isomer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Ding, J; Feng, JM; Geng, M; Gui, M; Huang, M; Li, M; Li, YX; Liu, CH; Shi, DK; Sun, QM; Zhang, J; Zhao, Y | 1 |
| Bartáček, J; Bhosale, DS; Dufková, L; Eyer, L; Fojtíková, M; Haviernik, J; Huvarová, I; Miller, AD; Růžek, D; Salát, J; Sedlák, M; Štefánik, M; Straková, P; Svoboda, J | 1 |
2 other study(ies) available for diphyllin and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase IIα.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Benzodioxoles; Biocatalysis; Cell Line, Tumor; Dioxolanes; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Glucosides; Glycosylation; Humans; Hydrolysis; Lignans; Mice; Mice, Inbred BALB C; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays | 2011 |
Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses.
Topics: Animals; Antigens, Viral; Antiviral Agents; Cell Line; Cell Survival; Glucosides; Lignans; Vacuolar Proton-Translocating ATPases; Virus Replication; Viruses | 2022 |